Effectiveness of a Multifaceted Informational-Based and Text Message Reminders on Pneumococcal and Influenza Vaccinations in Hospital Emergency Departments: A Cluster-Randomized Controlled Trial.
cluster-randomized trial
emergency departments
influenza vaccine
pneumococcal vaccine
reminder systems
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
28 Aug 2021
28 Aug 2021
Historique:
received:
07
07
2021
revised:
19
08
2021
accepted:
24
08
2021
entrez:
28
9
2021
pubmed:
29
9
2021
medline:
29
9
2021
Statut:
epublish
Résumé
We aimed to evaluate the effectiveness of a multifaceted procedure in improving pneumococcal and influenza vaccinations 6 months after an emergency department (ED) visit among patients aged 65 years and older. We conducted a cluster-randomized, controlled, parallel-group, open-label implementation trial in 18 EDs in France and Monaco. Participants were recruited from November 2015 to September 2016. EDs were randomly assigned with a 1:1 ratio to provide either a multifaceted procedure that combined structured information about pneumococcal and influenza vaccines and three text message reminders sent to patients every two weeks (intervention arm) or nonstructured information only (control arm). The outcomes were self-reported pneumococcal vaccination and influenza vaccination rates within 6 months of enrollment. A total of 9 EDs were randomized to the intervention arm (n = 780 patients) and 9 to the control arm (n = 695 patients). The median age for all enrolled patients was 74 years (25-75th percentiles, 69 to 82): 50.1% were male, 34.9% had at least one underlying condition, and 30.7% were at risk for invasive pneumococcal infection. In the intention-to-treat analysis, the multifaceted intervention did not alter the pneumococcal vaccination rate (6.4% versus 4.6%, absolute difference: 1.8; 95% CI: [-0.9 to 4.4]; A multifaceted intervention based on text message reminders provides an opportunity to increase anti-influenza vaccination among elderly patients visiting the ED. Efforts are warranted to provide better information on pneumococcal diseases and the benefits of pneumococcal vaccines, especially in the elderly.
Identifiants
pubmed: 34579199
pii: vaccines9090962
doi: 10.3390/vaccines9090962
pmc: PMC8473355
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Cochrane Database Syst Rev. 2018 Feb 01;2:CD004876
pubmed: 29388197
Hum Vaccin Immunother. 2021 Jan 2;17(1):162-169
pubmed: 32429734
Am J Public Health. 2019 Dec;109(12):1776-1783
pubmed: 31622142
Thorax. 2013 Nov;68(11):1057-65
pubmed: 24130229
PLoS One. 2018 Jun 14;13(6):e0198474
pubmed: 29902197
Vaccine. 2005 Jan 11;23(8):1048-52
pubmed: 15620478
Vaccine. 2015 Jan 9;33(3):459-64
pubmed: 25499651
JAMA. 2012 Apr 25;307(16):1702-8
pubmed: 22535855
BMJ. 2012 Sep 04;345:e5661
pubmed: 22951546
Cochrane Database Syst Rev. 2018 May 30;5:CD005188
pubmed: 29845606
Cochrane Database Syst Rev. 2018 Jan 18;1:CD003941
pubmed: 29342498
Hum Vaccin Immunother. 2020 Apr 2;16(4):851-857
pubmed: 31589554
Vaccine. 2015 Jul 17;33(31):3703-8
pubmed: 26073016
Ann Fam Med. 2017 Nov;15(6):507-514
pubmed: 29133488
Pediatrics. 2017 Jan;139(1):
pubmed: 27940512
PLoS One. 2017 Jan 6;12(1):e0169368
pubmed: 28061505
Wkly Epidemiol Rec. 2012 Nov 23;87(47):461-76
pubmed: 23210147
N Engl J Med. 2015 Mar 19;372(12):1114-25
pubmed: 25785969
MMWR Morb Mortal Wkly Rep. 2014 Sep 19;63(37):822-5
pubmed: 25233284
Vaccine. 2015 Aug 14;33(34):4180-90
pubmed: 25896377
Hum Vaccin Immunother. 2020;16(1):161-168
pubmed: 31343949
Acad Emerg Med. 2006 Sep;13(9):922-30
pubmed: 16902048
Vaccine. 2019 Jul 26;37(32):4454-4459
pubmed: 31277956
BMJ Open. 2016 Feb 19;6(2):e010069
pubmed: 26895984
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Jan;63(1):32-39
pubmed: 31802154